Amrita Hospital Faridabad hosted the 3rd International Conference on Healthcare Quality and Patient Safety which was organized by the National Quality of Care Network (NQOCN). The conference aimed to bring healthcare leaders, policymakers, and experts from around the world under one roof to discuss and
paying increased attention to rare diseases; allocation for treatment hiked to Rs 82 crore, up from zero just three years ago Successfully meeting the challenge of SMA would provide a model for effectively tackling other rare diseases in the country Rare diseases are receiving
In a ground-breaking achievement for India’s medical diagnostics sector, Erba Transasia proudly announces the commercial launch of the country’s first indigenously manufactured MonkeyPox PCR test kit. Validated by the Indian Council for Medical Research (ICMR), this kit today received emergency approval from Central Drugs Standard
Experts, including doctors and child psychologists, have commended the Indian government for its recent focus on the rigorous enforcement of the Prohibition of Electronic Cigarettes Act even as the United Kingdom government earlier this month announced its intention to restrict the marketing and sale of
The company has consolidated its position in ASEAN, South America and Eastern Europe regions Venus Remedies has taken another decisive step towards achieving its goal of emerging as the top oncology medicine supplier from India in the ASEAN region with the product registration from
The company has consolidated its position in GCC, ASEAN, Balkan and Caribbean regions with marketing approvals from Oman, Malaysia, Bosnia and Trinidad & Tobago for important chemotherapy drugs With this, the number of marketing approvals for its oncology products across 75 countries has gone
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans Venus Remedies Limited, a leading research-based pharmaceutical company, has achieved another significant milestone by securing a Good Manufacturing Practices (GMP) certification from
More than 40 lakh teenagers in the 15-18 age group received their first dose of Covid-19 vaccines on Monday as India began its drive to vaccinate the younger population groups. Some concerns were raised about ‘expired’ Covaxin being administered to this younger group, leading to
Health Ministry, Department of Biotechnology (DBT), WHO, JSS Academy of Higher Education and Research, BIRAC, AMTZ and Indian Pharmaceutical Alliance provide a unique learning platform The fourth of a series of six virtual workshops on current Good Manufacturing Practices to support the Indian pharmaceutical / Medical Devices industry’s vision of
States and union territories would aggregate the demand of private hospitals for Covid vaccines based on which the Centre will facilitate supply to these governments for timely and equitable distribution to smaller and remoter private healthcare facilities, according to the revised guidelines issued on Tuesday. Also,
